Health Care: Drugs

Orexigen Therapeutics Inc (OREX: NASDAQ)

$5.84 n/a | n/a%
11/26/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 5.84
52 Week High 7.82
52 Week Low 3.11
Avg. Daily Vol. (Mil) 4.50
Beta (3 year) 3.84
Share Related Items
Mkt Cap (Mil) 719.29
Shares Out (Mil) 123.17
Float (Mil) 91.70
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.90
Current Ratio 7.00
LT Debt/ Equity 4.91
Total Debt / Equity 4.91
Valuation Ratios
Price Earnings n.a.
Price/Sales 21.52
Price/Book 42.60
Price/Cash Flow -13.00
Per Share Data
Earnings -0.56
Sales 0.27
Book Value 0.14
Cash Flow -0.45
Business Summary
Orexigen Therapeutics Inc is a biopharmaceutical company. The Company is engaged in development of pharmaceutical product candidates for the treatment of obesity. Its product candidate includes NB32 and Empatic.
General Information
3344 North Torrey Pines Cour
Suite 200
La Jolla, CA 92037
www.orexigen.com
Industry : Drugs
Sector: Health Care
Employees: 50
CEO: Michael A. Narachi
Short Interest
Current Month (Mil) 39.76
Previous Month (Mil) 40.67
Short Interest Ratio (Days) 8.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -38.60
Return on Investments -59.70
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with OREX

Latest OREX Headlines from TheStreet

More Financial News for OREX

Press Releases for OREX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter